News for Onxeo SA (OXNXF)

High-grade gliomas are considered highly severe types of tumors. This health condition is typically found in adult and child populations. ...

/PRNewswire/ -- The HDAC (histone deacetylase) Inhibitors Market by Route of Administration, Distribution Channel, and Geography - Forecast and Analysis...

Onxeo SA press release (OXNXF): 1H GAAP EPS of -€0.11.The Group has not recorded any consolidated revenues for the period ended June 30, 2022.At June 30, 2022, the Group's cash...

Onxeo SA press release (OXNXF): FY the Group recorded a total net loss of €5.9M in 2021 versus a net profit of €1.1M in 2020Revenue of €4.06M (+128.1% Y/Y).At December 31, 2021, the...

/PRNewswire/ -- The HDAC (histone deacetylase) inhibitors market to grow by USD 162.42 mn from 2021 to 2026. The growth momentum of the market will decelerate...